Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-429P is a non-functional pseudogene derived from the U6 small nuclear RNA gene family, specifically the 429th annotated variant in the human genome. U6 snRNA is normally a component of the spliceosome, facilitating the removal of introns from pre-mRNA, but RNU6-429P does not encode a functional RNA molecule, contain essential protein interactions, or affect spliceosomal mechanisms. It is a remnant of gene duplication or retrotransposition events, retaining sequence similarity (~77% homology) with authentic U6 snRNA but lacking biological activity or regulatory function. Pseudogenes of U6 snRNA are common in the genome and serve no known biological, pharmaceutical, or diagnostic role.
None (no mechanism, as there are no known drugs or therapies targeting this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 429, pseudogene (RNU6-429P).